GabriellePrinceMD

PubMed

• 3 citations
  Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease.
  Khaled Sanber, Kevin Ye, Hua-Ling Tsai, Matthew Newman, Jonathan A Webster, Ivana Gojo, Gabriel Ghiaur, Gabrielle T Prince, Lukasz P Gondek, B Douglas Smith, Mark J Le...> ;Leukemia & Lymphoma. 2023 Apr 1
• 8 citations
  Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy.
  Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, Amy E DeZern, Gabriel Ghiaur, W Brian Dalton, Ivana Gojo, Gabrielle T Prince, Jonathan Webster, Alexander Ambinde...> ;Leukemia & Lymphoma. 2022 Aug 1
• 11 citations
  Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibr...
  Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah, Javier Bolaños-Meade, Leonido Luznik, Ephraim Fuchs, Richard Ambinder, Douglas E Gladstone, Ph...> ;Transplantation and Cellular Therapy. 2022 May 1
• 4 citations
  Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.
  Alexander J. Ambinder, Matthew D. Smith, Hua-Ling Tsai, Ravi Varadhan, Amy E. DeZern, William Dalton, Christian B. Gocke, Jonathan Webster, Lukasz P. Gondek, Ivana Goj...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Oct 9
• 37 citations
  Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
  Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova, Dominic T. Moore, Karen P. McKinnon, Alec D. Wilkinson, Rupkatha Mukhopadhyay, Francesco Mazziotta, Hanna A....> ;Blood Cancer Discovery. 2021 Sep 10
• 3 citations
  A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transpl...
  Jonathan Webster, Meera Yogarajah, Marianna Zahurak, Heather J. Symons, Amy E. DeZern, Ivana Gojo, Gabrielle T. Prince, Jillian Morrow, Richard J. Jones, B. Douglas Sm...> ;Leukemia & Lymphoma. 2021 Jul 21
• 21 citations
  Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide.
  Jonathan Webster, Leo Luznik, Hua Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark Levis, Ivana Gojo, Margaret M. Showel, Gabrielle T. Prince, Javier Bol...> ;Blood Advances. 2020 Oct 27
• 228 citations
  Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
  Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, Alice S. Mims, Gabrielle T. Prince, Jessica K. Altman, Martha Arellano, Will Donnellan, Harry P...> ;Blood. 2020 Feb 13
• 15 citations
  Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS
  Joshua F. Zeidner, Hanna A. Knaus, Amer M. Zeidan, Amanda L. Blackford, Raul Montiel-Esparza, Hubert Hackl, Gabrielle T. Prince, Lukasz P. Gondek, Gabriel Ghiaur, Marg...> ;Leukemia. 2020 Jan 3
• 8 citations
  Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
  Bryan C. Hambley, Kelly J. Norsworthy, Jagar Jasem, Jacquelyn W. Zimmerman, Eugene Shenderov, Jonathan Webster, Margaret M. Showel, Lukasz P. Gondek, William Brian Dal...> ;Leukemia Research. 2019 Jun 21
• 880 citations
  Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
  Courtney D. DiNardo, Eytan M. Stein, S. de Botton, Gail J. Roboz, Jessica K. Altman, Alice S. Mims, Ronan T. Swords, Robert H. Collins, Gabriel N. Mannis, Daniel A. Po...> ;The New England Journal of Medicine. 2018 Jun 2
• 7 citations
  Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients.
  Tara M. Robinson, Gabrielle T. Prince, Christopher J. Thoburn, Erica D. Warlick, Anna Ferguson, Yvette L. Kasamon, Ivan Borrello, Allan D. Hess, B. Douglas Smith> ;Leukemia & Lymphoma. 2018 Apr 4
• 10 citations
  Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
  Kelly J. Norsworthy, Amy E. DeZern, Hua Ling Tsai, Wesley Hand, Ravi Varadhan, Steven D. Gore, Ivana Gojo, Keith W. Pratz, Hetty E. Carraway, Margaret M. Showel, Micha...> ;Leukemia Research. 2017 Oct 1
• 31 citations
  Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy
  Meghali Goswami, Gabrielle T. Prince, Angelique Biancotto, Susan Moir, Lela Kardava, Brian H. Santich, Foo Cheung, Yuri Kotliarov, Jinguo Chen, Rongye Shi, Huizhi Zhou...> ;Journal of Translational Medicine. 2017 Jul 10
• 180 citations
  Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
  Yvette L. Kasamon, Javier Bolaños-Meade, Gabrielle T. Prince, Hua Ling Tsai, Shannon R. McCurdy, Jennifer A. Kanakry, Gary L. Rosner, Robert A. Brodsky, Karlo Perica, ...> ;Journal of Clinical Oncology. 2015 Aug 10
• 221 citations
  Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
  Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Hua Ling Tsai, Javier Bolaños-Meade, Gary L. Rosner, Christopher G. Kanakry, Karlo Perica, Heather J. Symo...> ;Blood. 2015 May 7
• 27 citations
  Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues
  Meghali Goswami, Nancy F. Hensel, B D Smith, Gabrielle T. Prince, Lu Qin, Hyam I. Levitsky, Stephen A. Strickland, Madan Jagasia, Bipin N. Savani, James W. Fraser, Hos...> ;Leukemia. 2014 Jan 10
• 19 citations
  Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy.
  Lu Qin, B. D. Smith, Hua-Ling Tsai, Nasser K. Yaghi, Poornima H. Neela, M. Moake, J. Fu, Yvette L. Kasamon, Gabrielle T. Prince, Meghali Goswami, Gary L. Rosner, Hyam ...> ;Blood Cancer Journal. 2013 Sep 6
• Join now to see all

Abstracts/Posters

• Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML
  Gabrielle T. Prince, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Ivosidenib (AG-120) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome: Updated Enrollment of a Phase 1 Dose Escalation and Expansion Study
  Gabrielle T. Prince, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (_6...
  Gabrielle T. Prince, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis
  Gabrielle T. Prince, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase IB Study of Blinatumomab (blina) in Patients with B Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or M...
  Gabrielle T. Prince, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all